Results from a new molecular study provide a framework to guide engineering of future SARS-CoV-2 vaccines.
Molecular research uncovers how these SARS-CoV-2 variants can erode vaccine immunity.
Emergency medical responders' training and use of personal protective equipment is credited for low rate of on-the-job infection.
Although children may have milder symptoms, they had similar levels of virus as symptomatic adults, researchers found.
Antibodies from recovered patients recognize a lesser-known site on the pandemic coronavirus and block infection in lab studies
The study highlights the value of establishing patients' viral loads and antibody levels upon hospital admission, the researchers say.
Preclinical data published in Cell show the nanoparticle vaccine spurs extremely high levels of protective antibodies in animal models.
Powerful antibody cocktail lock infection machinery, inhibits SARS-CoV-2 attachment to cells, and protects exposed animals.
SARS-CoV-2 usually triggers a strong immune response, but less so in men and people over 60.
Computer-designed, synthetic miniproteins act as potent, stable antivirals that block coronavirus infection of cultured human cells.
